Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Sundry Debtors

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹5,746 Cr₹4,817 Cr₹4,466 Cr₹4,012 Cr₹3,503 Cr

What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?

The latest Sundry Debtors ratio of AUROBINDO PHARMA is ₹5,746 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹5,746 Cr
Mar2024₹4,817 Cr
Mar2023₹4,466 Cr
Mar2022₹4,012 Cr
Mar2021₹3,503 Cr

How is Sundry Debtors of AUROBINDO PHARMA Trending?

Years Sundry Debtors % Change
Mar2025 ₹5,746 Cr
19.29
Mar2024 ₹4,817 Cr
7.84
Mar2023 ₹4,466 Cr
11.32
Mar2022 ₹4,012 Cr
14.53
Mar2021 ₹3,503 Cr -

Compare Sundry Debtors of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹62,894.8 Cr 4% -6.1% -28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4%

-6.1%

-28.4%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses